The Vaccine Development Landscape and Its Associated Challenges
Read Now!
Log in
Explore
Drug Knowledgebase
Start here! Dig into essential drug information
Interaction Checker
Check interactions in up to 5 drugs at a time
Advanced Exploration
Categories & ATC Classifications
Pathways
Drug Reactions
Drug Classification
Drug Targets
Advanced Search
Target Sequence
Spectra Search
Pharmaco-omics
Chemical Structure
For Drug Discovery
Use Case
Drug Discovery & Repurposing
Visit
DrugBank.com
for detailed drug and target data for your pharmaceutical research.
Products
Data Library
Explore detailed drug information packages to support your research & drug discovery.
Products
Data access in Snowflake
Increase scalability & security by streamlining data sharing & analysis in the cloud.
For Clinical Software
Clinical Intelligence API
Visit
DrugBank.com
to learn about our seamless integration into healthcare software.
Learn more about API Features
Drug Search
Drug-Drug Interaction Checker
Drug Allergy
US Drug Labels
For Academic Research
Log in
Drugs
Targets
Pathways
Indications
Drugs
Drugs
Targets
Pathways
Indications
Log in or create an account for full access to this data.
Create Account
Log in
Stage III Cutaneous Melanoma AJCC v7
Drug Trials
Drug
Drug Name
Drug Description
Drug
Drug Name
Target
Type
Drug
Drug Name
Phase
Status
Count
DB00041
Aldesleukin
1
Active Not Recruiting
1
DB00531
Cyclophosphamide
1
Active Not Recruiting
1
DB08912
Dabrafenib
1
Terminated
1
DB08912
Dabrafenib
1
Unknown Status
1
DB01073
Fludarabine
1
Active Not Recruiting
1
DB01611
Hydroxychloroquine
1
Active Not Recruiting
1
DB06186
Ipilimumab
1
Terminated
2
DB17107
Lifileucel
1
Active Not Recruiting
1
DB16828
MK-2206
1
Active Not Recruiting
1
DB09035
Nivolumab
1
Terminated
2
DB06306
Onalespib
1
Unknown Status
1
DB00740
Riluzole
1
Active Not Recruiting
1
DB06176
Romidepsin
1
Active Not Recruiting
1
DB08911
Trametinib
1
Terminated
1
DB08911
Trametinib
1
Unknown Status
1
DB00041
Aldesleukin
1 / 2
Completed
1
DB00531
Cyclophosphamide
1 / 2
Completed
1
DB01073
Fludarabine
1 / 2
Completed
1
DB05996
Glembatumumab vedotin
1 / 2
Withdrawn
1
DB06186
Ipilimumab
1 / 2
Completed
1
DB06186
Ipilimumab
1 / 2
Withdrawn
1
DB17107
Lifileucel
1 / 2
Completed
1
DB09035
Nivolumab
1 / 2
Completed
1
DB09035
Nivolumab
1 / 2
Withdrawn
1
DB09037
Pembrolizumab
1 / 2
Completed
1
DB08885
Aflibercept
2
Completed
1
DB00041
Aldesleukin
2
Completed
2
DB11967
Binimetinib
2
Active Not Recruiting
1
DB19293
CDX-301
2
Completed
1
DB19291
Cancer/testis antigen 1
2
Completed
1
DB11059
Carboxymethylcellulose
2
Completed
1
DB00531
Cyclophosphamide
2
Completed
1
DB08912
Dabrafenib
2
Active Not Recruiting
2
DB11718
Encorafenib
2
Active Not Recruiting
1
DB01073
Fludarabine
2
Completed
1
DB17293
Hiltonol
2
Completed
1
DB06186
Ipilimumab
2
Active Not Recruiting
1
DB00123
Lysine
2
Completed
1
DB15994
Methane
2
Active Not Recruiting
1
DB09035
Nivolumab
2
Active Not Recruiting
1
DB09037
Pembrolizumab
2
Active Not Recruiting
1
DB15185
Rasdegafusp alfa
2
Completed
1
DB00020
Sargramostim
2
Active Not Recruiting
1
DB13896
Talimogene laherparepvec
2
Active Not Recruiting
1
DB08911
Trametinib
2
Active Not Recruiting
2
DB06186
Ipilimumab
2 / 3
Recruiting
1
DB09035
Nivolumab
2 / 3
Recruiting
1
DB00020
Sargramostim
2 / 3
Recruiting
1